» Articles » PMID: 32923262

Choriocarcinoma Presenting As a Pleural Effusion

Overview
Journal Cureus
Date 2020 Sep 14
PMID 32923262
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Choriocarcinoma is a germ cell tumor characterized by widespread metastases and poorly differentiated cells. Non-gestational choriocarcinoma, or primary choriocarcinoma is a trophoblastic disease which is associated with a poor patient prognosis and is markedly angioinvasive. Primary non-gestational mediastinal choriocarcinoma is a very rare disease and represents an aggressive malignancy, primarily seen in young males. Those with primary mediastinal choriocarcinoma have symptoms that are non-specific such as cough, dyspnea, hemoptysis, and chest pain. Here we present the case of a 47-year-old Caucasian female who presented with worsening dyspnea and cough. Laboratory testing revealed elevated alkaline phosphatase, human chorionic gonadotropin, and cancer antigen 125. Chest X-ray was significant for a large right pleural effusion and a computed tomography angiogram of the chest showed a soft tissue mass in the anterior medial right lung base/right middle lobe. Thoracentesis yielded results consistent with malignant cells favoring a germ cell tumor. Biopsy of the mediastinal mass revealed positivity for inhibin and both human chorionic gonadotropin and CD-10 which led to the diagnosis of primary choriocarcinoma. Primary mediastinal choriocarcinoma is uncommon and often has a non-specific clinical presentation. A high degree of suspicion is needed as this malignancy can be aggressive, necessitating urgent definitive tissue biopsy diagnosis to guide appropriate therapy.

Citing Articles

Pembrolizumab for treatment of a male with primary mediastinal choriocarcinoma: a case report.

Pan W, Hou J Transl Cancer Res. 2022; 11(9):3416-3420.

PMID: 36237243 PMC: 9552051. DOI: 10.21037/tcr-22-766.


Primary non-gestational mediastinal choriocarcinoma metastatic to the brainstem.

De Jesus O, Pellot Cestero J, Gomez-Gonzalez F, Velez R BMJ Case Rep. 2022; 15(4).

PMID: 35365470 PMC: 8977749. DOI: 10.1136/bcr-2021-248389.

References
1.
Schmid P, Nagai Y, Agarwal R, Hancock B, Savage P, Sebire N . Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study. Lancet. 2009; 374(9683):48-55. DOI: 10.1016/S0140-6736(09)60618-8. View

2.
Dulmet E, Macchiarini P, Suc B, VERLEY J . Germ cell tumors of the mediastinum. A 30-year experience. Cancer. 1993; 72(6):1894-901. DOI: 10.1002/1097-0142(19930915)72:6<1894::aid-cncr2820720617>3.0.co;2-6. View

3.
Gaude G, Patil P, Malur P, Kangale R, Dhorigol V, Anurshetru S . Primary mediastinal choriocarcinoma. South Asian J Cancer. 2014; 2(2):79. PMC: 3876645. DOI: 10.4103/2278-330X.110495. View

4.
Batman S, Morgan T, Brunetti M, Strandabo R, Micci F, Moffitt M . Primary mediastinal choriocarcinoma in a female patient: Case report and review of the literature. Gynecol Oncol Rep. 2018; 26:99-101. PMC: 6232631. DOI: 10.1016/j.gore.2018.10.013. View

5.
Ronchi A, Cozzolino I, Montella M, Panarese I, Marino F, Rossetti S . Extragonadal germ cell tumors: Not just a matter of location. A review about clinical, molecular and pathological features. Cancer Med. 2019; 8(16):6832-6840. PMC: 6853824. DOI: 10.1002/cam4.2195. View